Key result
Progressive left ventricular dilation at 1 year was associated with a higher risk of death or cardiac transplantation up to 7 years later (HR 1.45; P<0.001).
Why the study?
Pediatric dilated cardiomyopathy frequently leads to death or cardiac transplantation, but whether changes in left ventricular dimensions and fractional shortening over time predict adverse outcomes was unclear.
Do changes in left ventricular remodeling parameters over 1 year predict death or cardiac transplantation in children with dilated cardiomyopathy?
Cohort (n=794)
Yes
Do changes in left ventricular remodeling parameters over 1 year predict death or cardiac transplantation in children with dilated cardiomyopathy?
Progressive deterioration in LV contractile function and increasing LV dilation over 1 year are associated with a higher risk of early and continuing mortality or transplantation in children with dilated cardiomyopathy.
May support serial LV monitoring for prognostication in pediatric DCM; leaves open whether remodeling-targeted therapies improve outcomes.
Background Pediatric dilated cardiomyopathy often leads to death or cardiac transplantation. We sought to determine whether changes in left ventricular (LV) end‐diastolic dimension (LVEDD), LV end‐diastolic posterior wall thickness, and LV fractional shortening (LVFS) over time may help predict adverse outcomes. Methods and Results We studied children up to 18 years old with dilated cardiomyopathy, enrolled between 1990 and 2009 in the Pediatric Cardiomyopathy Registry. Changes in LVFS, LVEDD, LV end‐diastolic posterior wall thickness, and the LV end‐diastolic posterior wall thickness:LVEDD ratio between baseline and follow‐up echocardiograms acquired ≈1 year after diagnosis were determined for children who, at the 1‐year follow‐up had died, received a heart transplant, or were alive and transplant‐free. Within 1 year after diagnosis, 40 (5.0%) of the 794 eligible children had died, 117 (14.7%) had undergone cardiac transplantation, and 585 (73.7%) had survived without transplantation. At diagnosis, survivors had higher median LVFS and lower median LVEDD Z scores. Median LVFS and LVEDD Z scores improved among survivors ( Z score changes of +2.6 and −1.1, respectively) but remained stable or worsened in the other 2 groups. The LV end‐diastolic posterior wall thickness:LVEDD ratio increased in survivors only, suggesting beneficial reverse LV remodeling. The risk for death or cardiac transplantation up to 7 years later was lower when LVFS was improved at 1 year (hazard ratio [HR], 0.83; P =0.004) but was higher in those with progressive LV dilation (HR, 1.45; P <0.001). Conclusions Progressive deterioration in LV contractile function and increasing LV dilation are associated with both early and continuing mortality in children with dilated cardiomyopathy. Serial echocardiographic monitoring of these children is therefore indicated. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00005391.
No takes yet. Share an insight, caveat, or question.
Kantor et al. (2024) conducted a cohort in Dilated cardiomyopathy (n=794). Progressive left ventricular dilation vs. No progressive left ventricular dilation was evaluated on Death or cardiac transplantation (HR 1.45, p=<0.001). Progressive left ventricular dilation at 1 year was associated with a higher risk of death or cardiac transplantation up to 7 years later (HR 1.45; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: